You just read:

Oxford BioTherapeutics Licenses Nerviano Medical Sciences' Drug-Linker Technology to Develop Novel Antibody Drug Conjugates

News provided by

Oxford BioTherapeutics

04 Apr, 2016, 09:23 BST